interferon

Documents about interferon

• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia#862271ClinicalTrials.gov
• Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon#1056928ClinicalTrials.gov
• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia#1047883ClinicalTrials.gov
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma#978931ClinicalTrials.gov
• Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis#1231272ClinicalTrials.gov
• Cognitive Effects of Interferon in Patients With Melanoma#1339997ClinicalTrials.gov
• Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma#903384ClinicalTrials.gov
• Interferon-γ-Induced Microglial Reprogramming#1590955UR Research
• Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation#865744ClinicalTrials.gov
• Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C#1429914ClinicalTrials.gov
• Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon#841127ClinicalTrials.gov
• Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a)#842882ClinicalTrials.gov
• An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial#1244679ClinicalTrials.gov
• Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon#180398ClinicalTrials.gov
• Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance#914914ClinicalTrials.gov
• Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia#1229517ClinicalTrials.gov
• Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C#1246048ClinicalTrials.gov
• The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis#905904ClinicalTrials.gov
• Natalizumab De-escalation With Interferon Beta-1b#1293251ClinicalTrials.gov
• Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）#1370111ClinicalTrials.gov
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection#1231821ClinicalTrials.gov
• Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects#1337771ClinicalTrials.gov
• Type I and type III interferon receptor knockout chickens: Novel models for unraveling interferon dynamics in influenza infection#141221bioRxiv / medRxiv
• Pregnancy in Type I Interferon Receptor (IFNAR2) Knockout Sheep Challenges the Accepted Paradigm for Pregnancy Recognition in Ruminants#1165397DigitalCommons@USU
• Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally#886367ClinicalTrials.gov
• Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma#1321469ClinicalTrials.gov
• Neutralizing Interferon Type 1 in Hidradenitis Suppurativa#1438916ClinicalTrials.gov
• Randomized Phase III of PRRT Versus Interferon#803293ClinicalTrials.gov
• Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy#849882ClinicalTrials.gov
• A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon#1101758ClinicalTrials.gov
• Interferon-α After DLI for the Prevention of Relapse#1280392ClinicalTrials.gov
• Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine#912660ClinicalTrials.gov
• Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies#1339906ClinicalTrials.gov
• PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy#1451846ClinicalTrials.gov
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients#896165ClinicalTrials.gov
• Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV#1195680ClinicalTrials.gov
• Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma#1486451ClinicalTrials.gov
• Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin#868500ClinicalTrials.gov
• A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia#805885ClinicalTrials.gov
• The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients#837306ClinicalTrials.gov
• Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study#908069ClinicalTrials.gov
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients#1164347ClinicalTrials.gov
• Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients#1185423ClinicalTrials.gov
• Interferon α 2b Pharmacovigilance Study#862075ClinicalTrials.gov
• Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin#872433ClinicalTrials.gov
• Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B#877976ClinicalTrials.gov
• Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia#879273ClinicalTrials.gov
• Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C#891686ClinicalTrials.gov
• Expression of IFN-epsilon in the Female Reproductive Tract#913814ClinicalTrials.gov
• Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b#966256ClinicalTrials.gov